Cost-effectiveness of triplet therapies in metastatic hormone-sensitive prostate cancer used in PEACE-1 and ARASENS

被引：0
|
作者：
Lester-Coll, Nataniel Hernan
Benjamin, David Joseph
Ribault, Helene
Foulon, Stephanie
Fizazi, Karim
Rezazadeh, Arash
机构：
[1] Univ Vermont, Larner Coll Med, Burlington, VT USA
[2] Hoag Family Canc Inst, Newport Beach, CA USA
[3] Unicancer, Paris, France
[4] Gustave Roussy Inst, Villejuif, France
[5] Univ Paris Saclay, Inst Gustave Roussy, Dept Canc Med, Villejuif, France
[6] Univ Calif Irvine, Div Hematol Oncol, Orange, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.222
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
222
引用
收藏
页码：222 / 222
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer
    Parikh, N. R.
    Chang, E. M.
    Nickols, N. G.
    Rettig, M.
    Raldow, A.
    King, C. R.
    Steinberg, M. L.
    Feng, F. Y.
    Spratt, D. E.
    Tran, P. T.
    Kishan, A. U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S100 - S100
  • [22] Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer
    Parikh, Neil R.
    Chang, Eric M.
    Nickols, Nicholas G.
    Rettig, Matthew B.
    Raldow, Ann C.
    Steinberg, Michael L.
    Koontz, Bridget F.
    Vapiwala, Neha
    Deville, Curtiland
    Feng, Felix Y.
    Spratt, Daniel E.
    Reiter, Robert E.
    Phillips, Ryan
    Ost, Piet
    Tran, Phuoc T.
    Kishan, Amar U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (04): : 917 - 926
  • [23] Metastatic hormone-sensitive prostate cancer
    Gravis, Gwenaelle
    Salem, Naji
    Walz, Jochen
    BULLETIN DU CANCER, 2015, 102 (01) : 57 - 64
  • [24] Triple therapy for metastatic castration sensitive prostate cancer: PEACE-1 trial
    Singh, Kirti
    INDIAN JOURNAL OF UROLOGY, 2022, 38 (04) : 323 - 324
  • [25] Cost-effectiveness of upfront therapeutic options in low-volume de novo metastatic hormone-sensitive prostate cancer
    Parikh, Neil Rohit
    Chang, Eric M.
    Nickols, Nicholas George
    Rettig, Matthew
    Raldow, Ann C.
    Steinberg, Michael L.
    Koontz, Bridget F.
    Vapiwala, Neha
    Deville, Curtiland
    Feng, Felix Y.
    Spratt, Daniel Eidelberg
    Reiter, Robert Evan
    Phillips, Ryan
    Tran, Phuoc T.
    Kishan, Amar Upadhyaya
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [26] Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis
    Uemura, Motohide
    Kikukawa, Hiroaki
    Hashimoto, Yasuhiro
    Uemura, Hiroji
    Mizokami, Atsushi
    Kato, Masashi
    Matsushima, Hisashi
    Kosaka, Takeo
    Nakamura, Motonobu
    Fukasawa, Satoshi
    Smith, Matthew R.
    Tombal, Bertrand
    Hussain, Maha
    Saad, Fred
    Fizazi, Karim
    Sternberg, Cora N.
    Crawford, E. David
    Kakiuchi, Haruka
    Akiyama, Masanao
    Li, Rui
    Kuss, Iris
    Joensuu, Heikki
    Suzuki, Hiroyoshi
    CANCER MEDICINE, 2024, 13 (21):
  • [27] ARASENS: making sense out of first-line metastatic hormone-sensitive prostate cancer treatment
    Aragon-Ching, Jeanny B.
    ASIAN JOURNAL OF ANDROLOGY, 2023, 25 (01) : 1 - 4
  • [28] Triplet Therapy: Entering the Metaverse of Metastatic Hormone-sensitive Prostate Cancer Treatment
    Dzimitrowicz, Hannah E.
    Armstrong, Andrew J.
    EUROPEAN UROLOGY, 2022, 82 (06) : 599 - 601
  • [29] Commentary on Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer
    Spencer, Katie L.
    Tree, Alison C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (04): : 927 - 929
  • [30] Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice
    Lendorf, Maria Elisabeth
    Petersen, Peter Meidahl
    Svendsen, Andrea Steen
    Lindberg, Henriette
    Brasso, Klaus
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 24 : 25 - 33
12345